Compare KOD & BRAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KOD | BRAI |
|---|---|---|
| Founded | 2009 | N/A |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | 2018 | N/A |
| Metric | KOD | BRAI |
|---|---|---|
| Price | $23.63 | $21.00 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $28.29 | N/A |
| AVG Volume (30 Days) | ★ 507.9K | 81.4K |
| Earning Date | 01-01-0001 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.60 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.92 | $12.56 |
| 52 Week High | $31.18 | $32.32 |
| Indicator | KOD | BRAI |
|---|---|---|
| Relative Strength Index (RSI) | 44.71 | 46.93 |
| Support Level | $21.19 | $12.83 |
| Resistance Level | $26.21 | $25.00 |
| Average True Range (ATR) | 1.63 | 6.44 |
| MACD | -0.33 | -0.22 |
| Stochastic Oscillator | 19.66 | 38.41 |
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.